Gene Therapy for Wet AMD

Clinical trial NCT05611424 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05611424
Sponsor: Frontera Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2023-05-01
Primary completion: 2024-11-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.